Cyteir Therapeutics Employee Directory
Research ServicesMassachusetts, United States0-1 Employees
Cyteir Therapeutics is a clinical-stage company in the research services sector, based in Lexington, Massachusetts. Its work centers on discovering and developing cancer therapies, including CYT-0851, an oral investigational agent that inhibits monocarboxylate transporters. CYT-0851 was being studied in combination with capecitabine and gemcitabine in a Phase 1/2 trial for patients with advanced ovarian cancer. Beyond its lead program, Cyteir has pursued a broader focus on synthetically lethal cancer therapies. Recent leadership changes include the promotion of David Gaiero to Chief Financial Officer in February 2023.